Beryllium Infliximab Study: Clinical Interventional Trial

Clinical trial NCT00111917 · TERMINATED

Trial details

NCT number: NCT00111917
Sponsor: Maier, Lisa, M.D.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Berylliosis Beryllium Disease

Start date: 2005-02-01
Primary completion: 2009-01-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.